次世代シーケンスCLIAラボラトリーサービス市場：技術、認証タイプ、用途、エンドユーザー別-2025-2030年世界予測

次世代シーケンスCLIAラボラトリーサービス市場の2023年の市場規模は58億1,000万米ドルで、2024年には67億8,000万米ドルに達すると予測され、2030年にはCAGR 13.97％で成長して145億2,000万米ドルになると予測されています。

次世代シーケンシング（NGS）CLIAラボサービスは、最先端のシーケンシング技術と厳格なラボ基準を組み合わせた臨床診断において極めて重要な分野です。CLIA（Clinical Laboratory Improvement Amendments）認証は、これらのラボが高品質の検査プロトコルを満たすことを保証し、それによって患者の検査結果の正確性、信頼性、適時性を保証します。NGS CLIAラボサービスの必要性は、疾患の早期発見、個別化医療、個人の遺伝子プロファイルに合わせた治療戦略を支援する包括的な遺伝子シーケンスを提供する能力にあります。その応用範囲は、がんゲノム、遺伝性疾患検査、感染症解析、薬理ゲノミクスに及ぶ。主なエンドユーザーには、病院、学術研究機関、診断研究所、製薬会社などがあります。注目すべき市場成長促進要因としては、遺伝性疾患やがんの有病率の上昇、NGS技術の進歩によるコスト削減、個別化医療に対する需要の高まりなどが挙げられます。最近のビジネスチャンスとしては、ゲノミクスにおけるデータ解析のための人工知能の統合、農村部や十分なサービスを受けていないヘルスケア環境への進出、戦略的パートナーシップによる国際市場への浸透などが挙げられます。しかし、遺伝子検査に関連する倫理的な懸念、機器や運用コストのための多額の初期投資、厳しい規制環境といった要因が市場成長の課題となっています。さらに、データ・プライバシーの問題や償還の制約も依然として大きな障壁となっています。それにもかかわらず、技術革新と研究のための最良の分野には、より効率的なバイオインフォマティクスツールとプラットフォームの開発、シーケンスの精度と速度の向上、非侵襲的検査法の探求などが含まれます。さらに、分野横断的なパートナーシップにより、新たな治療領域におけるNGSの有用性が拡大する可能性があります。市場は急速な技術進歩と激しい競争を特徴としており、市場シェアを効果的に獲得・維持するためには継続的なイノベーションと戦略的マーケティングが必要です。企業は、このダイナミックな環境に打ち勝つため、研究開発や戦略的提携に投資し、ヘルスケアの幅広いニーズに応える充実したサービスポートフォリオを提供することをお勧めします。

市場力学：急速に進化する次世代シーケンスCLIAラボラトリーサービス市場の主要市場インサイトを公開

次世代シーケンスCLIAラボラトリーサービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 伝染性および非伝染性疾患の急増と診断検査の必要性
  • 疾病のスクリーニングとモニタリング能力の強化に注力する政府の増加
  • がん研究に対する調査および投資の増加
• 市場抑制要因
  • 診断センターにおける熟練した専門家の不足
• 市場機会
  • NGSによるゲノムプロファイリングの臨床的有用性と有効性の向上
  • 次世代シーケンス技術の技術的進歩
• 市場の課題
  • バイオインフォマティクスと計算技術の複雑化

ポーターのファイブフォース：次世代シーケンスCLIAラボラトリーサービス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：次世代シーケンスCLIAラボラトリーサービス市場における外部からの影響の把握

外部マクロ環境要因は、次世代シーケンスCLIAラボラトリーサービス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析次世代シーケンスCLIAラボラトリーサービス市場における競合情勢の把握

次世代シーケンスCLIAラボラトリーサービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス次世代シーケンスCLIAラボラトリーサービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、次世代シーケンスCLIAラボラトリーサービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨次世代シーケンスCLIAラボラトリーサービス市場における成功への道筋を描く

次世代シーケンスCLIAラボラトリーサービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 伝染性疾患と非伝染性疾患の増加と診断検査の必要性
    • 疾病検査と監視能力の強化に政府が重点を置く
    • がん調査への調査と投資の増加
  • 抑制要因
    • 診断センターにおける熟練した専門家の不足
  • 機会
    • NGSによるゲノムプロファイリングの臨床的有用性と有効性の向上
    • 次世代シーケンシング技術の技術的進歩
  • 課題
    • バイオインフォマティクスとテクノロジーにおける計算上の複雑さ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 次世代シーケンスCLIAラボラトリーサービス市場：技術別

• 細胞フリーDNAシーケンシング
• メタゲノムシーケンシング
• NGS遺伝子パネルシーケンス
• ターゲットシーケンシングと再シーケンシング
• 全エクソーム配列解析
• 全ゲノム配列解析

第7章 次世代シーケンスCLIAラボラトリーサービス市場証明書の種類別

• 医療従事者が実施する顕微鏡検査の証明書
• 認定証
• コンプライアンス証明書
• 登録証明書
• 免除証明書

第8章 次世代シーケンスCLIAラボラトリーサービス市場：用途別

• バイオマーカーの発見
• 診断
• 創薬
• 精密医療

第9章 次世代シーケンスCLIAラボラトリーサービス市場：エンドユーザー別

• 診断センター
• 病院

第10章 南北アメリカの次世代シーケンスCLIAラボラトリーサービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の次世代シーケンスCLIAラボラトリーサービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの次世代シーケンスCLIAラボラトリーサービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Azenta Life Sciences
• Beijing Genomics Co. Ltd.
• Bio-Rad Laboratories, Inc.
• BioMerieux S.A.
• Charles River Laboratories, Inc.
• Eurofins Scientific SE
• F. Hoffmann-La Roche AG
• Illumina, Inc.
• Macrogen, Inc.
• NanoString Technologies, Inc.
• Perkin Elmer, Inc.
• PierianDx, Inc.
• Pillar Biosciences, Inc.
• Qiagen N.V.
• Saphetor SA
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CELL FREE DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY NGS GENE PANEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE FOR PROVIDER-PERFORMED MICROSCOPY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF ACCREDITATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF REGISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF WAIVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 41. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 43. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 63. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 65. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 67. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 69. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 136. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 138. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 152. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 154. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 156. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 158. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 196. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 197. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Next Generation Sequencing CLIA Laboratory Services Market was valued at USD 5.81 billion in 2023, expected to reach USD 6.78 billion in 2024, and is projected to grow at a CAGR of 13.97%, to USD 14.52 billion by 2030.

Next Generation Sequencing (NGS) CLIA Laboratory Services represent a pivotal area in clinical diagnostics, combining cutting-edge sequencing technologies with rigorous laboratory standards. The Clinical Laboratory Improvement Amendments (CLIA) certification ensures that these labs meet high-quality testing protocols, thereby assuring accuracy, reliability, and timeliness of patient test results. The necessity of NGS CLIA lab services lies in their ability to offer comprehensive genetic sequencing that aids in early disease detection, personalized medicine, and treatment strategies tailored to individual genetic profiles. Their application spans cancer genomics, hereditary disease testing, infectious disease analysis, and pharmacogenomics. Key end-users include hospitals, academic research institutes, diagnostic laboratories, and pharmaceutical companies. Notably, factors driving market growth include the rising prevalence of genetic disorders and cancer, advancements in NGS technology reducing costs, and the increasing demand for personalized medicine. Recent opportunities highlight the integration of artificial intelligence for data analytics in genomics, expansion into rural and underserved healthcare settings, and international market penetration through strategic partnerships. However, market growth is challenged by factors such as ethical concerns related to genetic testing, significant initial investment for equipment and operational costs, and a stringent regulatory environment. Furthermore, data privacy issues and reimbursement constraints remain salient barriers. Nonetheless, the best areas for innovation and research include developing more efficient bioinformatics tools and platforms, improving sequencing accuracy and speed, and exploring non-invasive testing methods. Additionally, cross-disciplinary partnerships could expand the utility of NGS in new therapeutic areas. The market is characterized by rapid technological advancements and intense competition, necessitating continuous innovation and strategic marketing to capture and retain market share effectively. Companies are advised to invest in R&D and strategic collaborations to excel in this dynamic environment, offering enriched service portfolios that cater to a broad array of healthcare needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next Generation Sequencing CLIA Laboratory Services Market

The Next Generation Sequencing CLIA Laboratory Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Proliferation of communicable and noncommunicable disorders and need for diagnostic testing
  • Increasing government focus on enhancing disease screening and monitoring capabilities
  • Rising research and investments in cancer research
• Market Restraints
  • Limited availability of skilled professionals in diagnostic centers
• Market Opportunities
  • Improvements in clinical utility and efficacy of genomic profiling with the NGS
  • Technological advances in next generation sequencing technologies
• Market Challenges
  • Bioinformatics and computational complications in technology

Porter's Five Forces: A Strategic Tool for Navigating the Next Generation Sequencing CLIA Laboratory Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next Generation Sequencing CLIA Laboratory Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next Generation Sequencing CLIA Laboratory Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next Generation Sequencing CLIA Laboratory Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next Generation Sequencing CLIA Laboratory Services Market

A detailed market share analysis in the Next Generation Sequencing CLIA Laboratory Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next Generation Sequencing CLIA Laboratory Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next Generation Sequencing CLIA Laboratory Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next Generation Sequencing CLIA Laboratory Services Market

A strategic analysis of the Next Generation Sequencing CLIA Laboratory Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next Generation Sequencing CLIA Laboratory Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Azenta Life Sciences, Beijing Genomics Co. Ltd., Bio-Rad Laboratories, Inc., BioMerieux S.A., Charles River Laboratories, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina, Inc., Macrogen, Inc., NanoString Technologies, Inc., Perkin Elmer, Inc., PierianDx, Inc., Pillar Biosciences, Inc., Qiagen N.V., Saphetor SA, Takara Bio Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Next Generation Sequencing CLIA Laboratory Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Cell Free DNA Sequencing, Metagenomic Sequencing, NGS Gene Panel Sequencing, Targeted Sequencing & Re-sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.
• Based on Certificate Types, market is studied across Certificate for Provider-Performed Microscopy Procedures, Certificate of Accreditation, Certificate of Compliance, Certificate of Registration, and Certificate of Waiver.
• Based on Application, market is studied across Biomarker Discovery, Diagnostics, Drug Discovery, and Precision Medicine.
• Based on End-users, market is studied across Diagnostic Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Proliferation of communicable and noncommunicable disorders and need for diagnostic testing
    • 5.1.1.2. Increasing government focus on enhancing disease screening and monitoring capabilities
    • 5.1.1.3. Rising research and investments in cancer research
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of skilled professionals in diagnostic centers
  • 5.1.3. Opportunities
    • 5.1.3.1. Improvements in clinical utility and efficacy of genomic profiling with the NGS
    • 5.1.3.2. Technological advances in next generation sequencing technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Bioinformatics and computational complications in technology
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Next Generation Sequencing CLIA Laboratory Services Market, by Technology

• 6.1. Introduction
• 6.2. Cell Free DNA Sequencing
• 6.3. Metagenomic Sequencing
• 6.4. NGS Gene Panel Sequencing
• 6.5. Targeted Sequencing & Re-sequencing
• 6.6. Whole Exome Sequencing
• 6.7. Whole Genome Sequencing

7. Next Generation Sequencing CLIA Laboratory Services Market, by Certificate Types

• 7.1. Introduction
• 7.2. Certificate for Provider-Performed Microscopy Procedures
• 7.3. Certificate of Accreditation
• 7.4. Certificate of Compliance
• 7.5. Certificate of Registration
• 7.6. Certificate of Waiver

8. Next Generation Sequencing CLIA Laboratory Services Market, by Application

• 8.1. Introduction
• 8.2. Biomarker Discovery
• 8.3. Diagnostics
• 8.4. Drug Discovery
• 8.5. Precision Medicine

9. Next Generation Sequencing CLIA Laboratory Services Market, by End-users

• 9.1. Introduction
• 9.2. Diagnostic Centers
• 9.3. Hospitals

10. Americas Next Generation Sequencing CLIA Laboratory Services Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Next Generation Sequencing CLIA Laboratory Services Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Next Generation Sequencing CLIA Laboratory Services Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Azenta Life Sciences
• 3. Beijing Genomics Co. Ltd.
• 4. Bio-Rad Laboratories, Inc.
• 5. BioMerieux S.A.
• 6. Charles River Laboratories, Inc.
• 7. Eurofins Scientific SE
• 8. F. Hoffmann-La Roche AG
• 9. Illumina, Inc.
• 10. Macrogen, Inc.
• 11. NanoString Technologies, Inc.
• 12. Perkin Elmer, Inc.
• 13. PierianDx, Inc.
• 14. Pillar Biosciences, Inc.
• 15. Qiagen N.V.
• 16. Saphetor SA
• 17. Takara Bio Inc.
• 18. Thermo Fisher Scientific, Inc.